Replies to post #166742 on Biotech Values

[dav1234]

Superb call on ENTA ..congrats.. Do u ever reduce a position based on gains % or just ride until thesis for holding changes??

[jq1234]

It's parabolic! Did they guide they'd release ph3 results as they come in or they'd wait and group some together?

[mcbio]

Medivir shares

ENTA (26.04 +6%) continues rise on high (i.e. new normal) volume.

ENTA isn't the only HCV name doing well these days. Shares of Medivir closed at a 52-week high today at 100.50 on their local exchange. ; ) Been a nice rebound of late. Looks like I'm up about 50% from my cost and I'm sitting on LT cap gains. I'm not going to get a big head though with key binary events coming in the approval decisions in Japan, U.S., and EU for simeprevir. Been doing this long enough to know that things can reverse course quickly. That said, my gut remains to continue to hold at least past the approval decisions in each of those three markets (obviously I'm betting on approval in those three markets).